Tryptophan breakdown and depression
Part of Mental health clinical trials.
This study looks at how the body breaks down tryptophan (a protein building block) and whether that process is linked to depression. It may help find new ways to diagnose or treat depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have not taken any depression medication for at least 4 months.
- You do not have other mental health conditions like anxiety or substance use disorder.
- You do not have psychotic symptoms (like hallucinations or delusions).
- You do not have depression after childbirth.
- You do not have a chronic illness that affects your immune system and you are not on immune-affecting drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study explores how gut bacteria and serotonin (a brain chemical linked to mood) may be connected in people with depression, anxiety, PTSD, or panic disorder. By analyzing your gut microbiome (the bacteria in your digestive system) alongside genetic information, researchers hope to better understand these mental health conditions.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial tests if inhaling DMT can help treat moderate to severe major depression. You may qualify if your depression has lasted at least two weeks and you have not changed medications recently.
This study is collecting detailed information from people with depression and from healthy volunteers to better understand the biological factors involved. Participants will provide samples and complete assessments to help researchers identify new ways to diagnose and treat depression.
This trial tests an experimental oral medication, SPT-300, for people with major depressive disorder, even if they also have mild anxiety. The goal is to see if it helps improve mood safely.
This trial looks at brain and genetic markers to understand why depression returns. It is for people with major depression who are not currently taking medication.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.